NCT03514121 2024-11-22
FPA150-001
Five Prime Therapeutics, Inc.
Phase EARLY_PHASE1 Terminated
Clinical Trials
4 trialsNCT03382574 2022-06-14
Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-Oophorectomy
National Cancer Institute (NCI)
Phase EARLY_PHASE1 Terminated
NCT01705288 2020-02-17
Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
Masonic Cancer Center, University of Minnesota
Phase EARLY_PHASE1 Completed
NCT02411565 2019-01-23
Fermented Wheat Germ Extract in Women With Ovarian Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Terminated